Fernand Labrie
Publications
Page 14 of 26, showing 50 records out of 1263 total, starting on record 651, ending on 700
| Publication | Category | Year |
|---|---|---|
| 1052. Zhao, H.F., Rhéaume, E., Trudel, C., Couet, J., Labrie, F., Simard, J. (1990) Structure and sexual dimorphic expression of a liver-specific rat 3beta-hydroxysteroid dehydrogenase/isomerase. Endocrinology, 127: 3237-3239. | All publications | 1990 |
| 4069. Zorilla, R., Simard, J., Rhéaume, E., Labrie, F., Pelletier, G. (1990) Multihormonal control of pre-prosomatostatin mRNA levels in the periventricular nucleus of the male and female rat hypothalamus. Neuroendocrinology, 52: 527-536. | All publications | 1990 |
| 178. Bélanger, B., Bélanger, A., Labrie, F., Dupont, A., Cusan, L., Monfette, G. (1989) Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men. J. Steroid Biochem., 32: 695-698. | All publications | 1989 |
| 1054. Bérubé, D., Luu-The, V., Lachance, Y., Gagné, R., Labrie, F. (1989) Assignment of the human 3beta-hydroxysteroid dehydrogenase gene to the p13 band of chromosome 1. Cytogenet. Cell. Genet., 52: 199-200. | All publications | 1989 |
| 501. Dauvois, S., Labrie, F. (1989) Androstenedione and androst-5-ene-3beta, 17beta-diol stimulate DMBA-induced rat mammary tumors-role of aromatase. Breast Cancer Res. Treat., 13: 61-69. | All publications | 1989 |
| 502. Dauvois, S., Li, S., Martel, C., Labrie, F. (1989) Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat. Breast Cancer Res. Treat., 14: 299-306. | All publications | 1989 |
| 503. Dauvois, S., Spinola, P.G., Labrie, F. (1989) Additive inhibitory effects of bromocriptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat. Eur. J. Cancer Clin. Oncol., 25: 891-897. | All publications | 1989 |
| 504. Dumont, M., Dauvois, S., Simard, J., Garcia, T., Schachter, B., Labrie, F. (1989) Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer. J. Steroid Biochem., 34: 397-402. | All publications | 1989 |
| 179. Dupont, A., Labrie, F., Manhès, G., Bergeron, N., Cusan, L., Pinault, S., Bélanger, A., Boucher, M., Lacourcière, Y., Emond, J. (1989) Combination therapy with Flutamide and the LHRH agonist [D-Trp6, des-Gly-NH210]LHRH ethylamide in stage C prostatic carcinoma, in: Labrie, F., Lee, F. et Dupont, A., eds: Early Stage Prostate Cancer: Diagnosis and Choice of Therapy, North Holland, Elsevier, ICS 841, pp 89-102. | All publications | 1989 |
| 180. Emond, J., Dupont, A., Cusan, L., Bergeron, N., Manhès, G., Labrie, F. (1989) Combination therapy with Flutamide and castration (LHRH agonist or orchiectomy) as an alternative to transurethral resection of the prostate for urinary retention in prostate cancer, in: Labrie, F., Lee, F. et Dupont, A., eds: Early Stage Prostate Cancer: Diagnosis and Choice of Therapy, North Holland, Elsevier, pp 103-108. | All publications | 1989 |
| 181. Labrie, C., Simard, J., Marchetti, B., Pelletier, G., Zhao, H.F., Bélanger, A., Labrie, F. (1989) Conversion of precursor adrenal steroids into potent androgens in peripheral tissue, in: Labrie, F., Lee, F. et Dupont, A., eds: Early Stage Prostate Cancer: Diagnosis and Choice of Therapy, North Holland, Elsevier, ICS 841, pp 1-22. | All publications | 1989 |
| 182. Labrie, C., Simard, J., Zhao, H., Bélanger, A., Pelletier, G., Labrie, F. (1989) Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology, 124: 2745-2754. | All publications | 1989 |
| 183. Labrie, F. (1989) Criteria of response of stage D2 prostate cancer [Letter to the Editor: Reply to Newling et al. re 24: 1869-78, 1988]. Eur. J. Cancer Clin. Oncol., 25: 1259-1260. | All publications | 1989 |
| 184. Labrie, F. (1989) Medical treatment of prostate cancer. Drug Therapy, 19: 22-37. | All publications | 1989 |
| 185. Labrie, F., Dupont, A., Bélanger, A., Cusan, L., Brochu, M., Turina, E., Pinault, S., Lacourcière, Y., Emond, J. (1989) Anti-hormone treatment in stage D2 prostate cancer patients relapsing under treatment with Flutamide and castration: addition of aminoglutethimide and low dose hydrocortisone to combination therapy. Br. J. Urol., 63: 634-638. | All publications | 1989 |
| 186. Labrie, F., Dupont, A., Cusan, L., Giguère, M., Bergeron, N., Lacourcière, Y., Bélanger, A., Monfette, G., Emond, J. (1989) Terapia combinada con flutamida y (D-TRP6)LH-RH etilamida en el cancer de prostata en estadio D2 sin tratamiento previo, in: Pontes, J.E., Mallo, N. et Zungri, E., eds: Cancer de Prostata, ulso Ediciones, Barcelona, Actualizaciones Urologicas, pp 73-86. | All publications | 1989 |
| 187. Labrie, F., Dupont, A., Cusan, L., Labrie, C., Lacoste, D., Luu-The, V., Manhès, G., Lacourcière, Y., Pinault, S., Bélanger, A., Monfette, G., Emond, J. (1989) Today's endocrine therapy of prostate cancer, in Fourth International Symposium on Transrectal Ultrasound in the Diagnosis and Management of Prostate Cancer, New York, Alan R. Liss Inc., pp 223-235. | All publications | 1989 |
| 188. Labrie, F., Dupont, A., Cusan, L., Manhès, G., Bergeron, N., Lacourcière, Y., Pinault, S., Bélanger, A., Monfette, G., Emond, J. (1989) Combination therapy with castration and flutamide: to-day's treatment of choice for prostate cancer. J. Steroid Biochem., 33: 817-821. | All publications | 1989 |
| 189. Labrie, F., Dupont, A., Cusan, L., Manhès, G., Bergeron, N., Lacourcière, Y., Pinault, S., Bélanger, A., Monfette, G., Emond, J. (1989) Combination therapy with Flutamide and castration: its benefits at various stages of prostate cancer, in: Murphy, G.P. et Khoury, S., eds: Progress in Clinical and Biological Research, New York, Alan R. Liss Inc., pp 161-167. | All publications | 1989 |
| 190. Labrie, F., Dupont, A., Cusan, L., Manhès, G., Bergeron, N., Lacourcière, Y., Pinault, S., Bélanger, A., Monfette, G., Emond, J. (1989) LHRH agonists and prostate cancer: an example of rapid development of a new class of drugs, in: Chiou, S.H., Wang, K.T. et Wu, S.H., eds: International Symposium on Biologically Active Proteins and Peptides, July 13-15, 1988, Taipei, Taiwan, pp 129-136. | All publications | 1989 |
| 4088. Labrie, F., Lacourciere, Y., Bélanger, A., Monfette, G., Bergeron, N., Dupont, A., Pinault, S., Emond, J., Manhes, G., Cusan, L. (1989) [Total androgen blockade: an argument in favor]. Union Med. Can., 118: 5. | All publications | 1989 |
| 4089. Labrie, F., Luu-The, V., Labrie, C., Bérubé, D., Couet, J., Zhao, H.F., Gagné, R., Simard, J. (1989) Characterization of two mRNA species encoding human estradiol 17?-dehydrogenase and assignment of the gene to chromosome 17. J. Steroid Biochem., 34: 189-197. | All publications | 1989 |
| 191. Lacoste, D., Caron, S., Bélanger, A., Labrie, F. (1989) Effect of 3-week treatment with [D-Trp6, des-Gly-NH210]LHRH ethylamide, aminoglutethimide, ketoconazole or Flutamide alone or in combination on testicular, serum, adrenal and prostatic steroid levels in the dog. J. Steroid Biochem., 33: 233-242. | All publications | 1989 |
| 192. Lacoste, D., Dubé, D., Bélanger, A., Labrie, F. (1989) Effect of 2-week combination therapy with the LHRH agonist [D-Trp6,des-Gly-NH2]LHRH ethylamide and the antiandrogen Flutamide on prostate structure and steroid levels in the dog. Mol. Cell. Endocrinol., 67: 131-138. | All publications | 1989 |
| 193. Lacoste, D., Dubé, D., Trudel, C., Bélanger, A., Labrie, F. (1989) Normal gonadal functions and fertility after 23 months of treatment of prepubertal male and female dogs with the GnRH agonist [D-Trp6,des-Gly-NH210]LHRH ethylamide. J. Androl., 10: 456-465. | All publications | 1989 |
| 194. Lacoste, D., Labrie, F., Dubé, D., Bélanger, A., Tice, T., Gilley, R.M., Pledger, K.L. (1989) Reversible inhibition of testicular androgen secretion by 3-, 5- and 6-month controlled-release microsphere formulations of the LHRH agonist [D-Trp6,des-Gly-NH210]LHRH ethylamide in the dog. J. Steroid Biochem., 33: 1007-1011. | All publications | 1989 |
| 4094. Luu-The, V., Labrie, C., Zhao, H.F., Couet, J., Lachance, Y., Simard, J., Leblanc, G., Côté, J., Bérubé, D., Gagné, R., Labrie, F. (1989) Characterization of cDNAs for human estradiol 17?-dehydrogenase and assigment of the gene to chromosome 17: evidence of two mRNA species with distinct 5' termini in human placenta. Mol. Endocrinol, 3: 1301-1309. | All publications | 1989 |
| 4095. Luu-The, V., Lachance, Y., Labrie, C., Leblanc, G., Thomas, J.L., Strickler, R.C., Labrie, F. (1989) Full length cDNA structure and deduced amino acid sequence of human 3?-hydroxy-5-ene steroid dehydrogenase. Mol. Endocrinol., 3: 1310-1312. | All publications | 1989 |
| 505. Marchetti, B., Spinola, P., Plante, M., Poyet, P., Folléa, N., Pelletier, G., Labrie, F. (1989) ?-adrenergic receptors in dimethylbenz(?)anthracene(DMBA)-induced rat mammary tumors: Correlation with progesterone receptor levels and tumor growth. Breast Cancer Res. Treat., 13: 251-263. | All publications | 1989 |
| 195. Monfette, G., Dupont, A., Labrie, F. (1989) Temporary combination therapy with Flutamide and Tryptex as adjuvant to radical prostatectomy for the treatment of early stage prostate cancer, in: Labrie, F., Lee, F. et Dupont, A., eds: Early Stage Prostate Cancer: Diagnosis and Choice of Therapy, North Holland, Elsevier, ICS 841, pp 41-42. | All publications | 1989 |
| 196. Monfette, G., Dupont, A., Pinault, S., Gagnon, J., Boivin, J.C., Têtu, B., Labrie, F. (1989) Advantages of downstaging local prostate cancer by 3-month combination therapy prior to radical prostatectomy, in Fourth International Symposium on Transrectal Ultrasound in the Diagnosis and Management of Prostate Cancer, New York, Alan R. Liss Inc., pp 255-261. | All publications | 1989 |
| 4099. Pelletier, G., Tong, Y., Simard, J., Zhao, H.F., Labrie, F. (1989) Localization of peptide gene expression by in situ hybridization at the electron microscopic level, in: Conn, M., ed. Methods in Neurosciences, New York, NY, USA, Academic Press, pp 197-208. | All publications | 1989 |
| 197. Pinault, S., Gagnon, J., Monfette, G., Têtu, B., Dupont, A., Labrie, F. (1989) Transrectal ultrasound evaluation of local disease in prostate cancer patients treated with the combination therapy, in: Labrie, F., Lee, F. et Dupont, A., eds: Early State Prostate Cancer: Diagnosis and Choice of Therapy, North Holland, Elsevier, ICS 841, pp 53-62. | All publications | 1989 |
| 506. Poulin, R., Baker, D., Poirier, D., Labrie, F. (1989) Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast Cancer Res. Treat., 13: 161-172. | All publications | 1989 |
| 507. Poulin, R., Dufour, J.-M., Labrie, F. (1989) Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin. Breast Cancer Res. Treat., 13: 265-276. | All publications | 1989 |
| 508. Poulin, R., Mérand, Y., Poirier, D., Lévesque, C., Dufour, J.M., Labrie, F. (1989) Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen and ICI 164384, a new steroidal derivative, in ZR-75-1 human breast cancer cells. Breast Cancer Res. Treat., 14: 65-76. | All publications | 1989 |
| 509. Poulin, R., Poirier, D., Mérand, Y., Thériault, C., Bélanger, A., Labrie, F. (1989) Extensive esterification of adrenal C19-?5 sex steroids to long-chain fatty acids in the ZR-75-1 human breast cancer cell line. J. Biol. Chem., 264: 9335-9343. | All publications | 1989 |
| 510. Poulin, R., Simard, J., Labrie, C., Petitclerc, L., Dumont, M., Lagacé, L., Labrie, F. (1989) Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line. Endocrinology, 125: 392-399. | All publications | 1989 |
| 511. Simard, J., Hatton, A.-C., Labrie, C., Dauvois, S., Zhao, H., Haagensen, D.E., Labrie, F. (1989) Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells. Mol. Endocrinol., 3: 694-702. | All publications | 1989 |
| 198. Têtu, B., Labrie, F., Dupont, A., Monfette, G. (1989) Histopathologic effect of combination therapy on normal prostate and prostatic adenocarcinoma, in: Labrie, F., Lee, F. et Dupont, A., eds: Early Stage Prostate Cancer: Diagnosis and Choice of Therapy, Exerpta Medica ICS 841, pp 63-76. | All publications | 1989 |
| 1066. Tong, Y., Simard, J., Labrie, C., Zhao, H.F., Labrie, F., Pelletier, G. (1989) Inhibitory effect of androgen on estrogen-induced prolactin messenger ribonucleic acid accumulation in the male rat anterior pituitary gland. Endocrinology, 125: 1821-1828. | All publications | 1989 |
| 4109. Tong, Y., Zhao, H., Labrie, F., Pelletier, G. (1989) Ontogeny of prolactin mRNA in the rat pituitary gland as evaluated by in situ hybridization. Mol. Cell. Endocrinol., 67: 11-16. | All publications | 1989 |
| 4110. Tong, Y., Zhao, H., Simard, J., Labrie, F., Pelletier, G. (1989) Electron microscopic autoradiographic localization of prolactin mRNA in rat pituitary. J. Histochem. Cytochem., 37: 567-571. | All publications | 1989 |
| 1067. Toranzo, D., Dupont, E., Simard, J., Labrie, C., Couet, J., Labrie, F., Pelletier, G. (1989) Regulation of pro-gonadotropin-releasing hormone (GnRH) gene expression by sex steroids in the brain of male and female rats. Mol. Endocrinol., 3: 1748-1756. | All publications | 1989 |
| 1068. Tremblay, Y., Ringler, G.E., Morel, Y., Mohandas, T.K., Labrie, F., Strauss, J.F., Miller, W.L. (1989) Regulation of the gene for estrogenic 17-ketosteroid reductase lying on chromosome 17-cenq25. J. Biol. Chem., 264: 20458-20462. | All publications | 1989 |
| 4113. Zhao, H.F., Simard, J., Labrie, C., Breton, N., Rhéaume, R., Luu-The, V., Labrie, F. (1989) Molecular cloning, cDNA structure and predicted amino acid sequence of bovine 3?-hydroxy-5-ene-steroid dehydrogenase ?5-?4 isomerase. FEBS Lett., 259: 153-157. | All publications | 1989 |
| 4114. Ayoub, J., Audet-Lapointe, P., Méthot, Y., Hanley, J., Cormier, A., Déry, J.P., Gauthier, P., Guay, J.P., Husson, D., Labrie, F., Lambert, B., Mandeville, R., Michon, B., Sidrac, S., Simard, A., Simard, P., Stanimir, G., Vauclair, R. (1988) Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone-receptor status. Gynecol. Oncol., 31: 327-337. | All publications | 1988 |
| 199. Bégin, D., Luthy, I.A., Labrie, F. (1988) Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro. Mol. Cell. Endocrinol., 58: 213-219. | All publications | 1988 |
| 200. Bélanger, A., Giasson, M., Cliche, J., Dupont, A., Labrie, F. (1988) Plasma levels of hydroxy-flutamide in patients with prostatic cancer receiving the combined hormonal therapy: an LHRH agonist and flutamide. Prostate, 12: 79-84. | All publications | 1988 |
| 201. Belanger, A., Labrie, F., Dupont, A., Brochu, M., Cusan, L. (1988) Endocrine effects of combined treatment with an LHRH agonist in association with Flutamide in metastatic prostatic carcinoma. Clin. Invest. Med., 11: 321-326. | All publications | 1988 |